Semaglutide, Chronic Kidney Disease, and Diabetes | NEJM

Name: Semaglutide, Chronic Kidney Disease, and Diabetes | NEJM
Uploaded: 2024-07-11T00:00:00
Description: Semaglutide reduces major kidney disease event risk by 24% in patients with type 2 diabetes and chronic kidney disease. Slows decline in kidney function.

1 min read

Medical Disclaimer: This content is for educational purposes only and is not medical advice. Consult a qualified professional for medical decisions.